Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Non-targeted Proteomics Newborn Screening Platform for Inborn Errors of Immunity.
Shibata H, Nakajima D, Konno R, Hijikata A, Higashiguchi M, Nihira H, Shimodera S, Miyamoto T, Nishitani-Isa M, Hiejima E, Izawa K, Takita J, Heike T, Okamura K, Ohnishi H, Ishimura M, Okada S, Yamashita M, Morio T, Kanegane H, Imai K, Nakamura Y, Nonoyama S, Uchiyama T, Onodera M, Nishikomori R, Ohara O, Kawashima Y, Yasumi T. Shibata H, et al. Among authors: higashiguchi m. J Clin Immunol. 2024 Oct 25;45(1):33. doi: 10.1007/s10875-024-01821-7. J Clin Immunol. 2024. PMID: 39453496 Free PMC article.
Circulating tumor-associated antigen-specific IFNγ+4-1BB+ CD8+ T cells as peripheral biomarkers of treatment outcomes in patients with pancreatic cancer.
Murakami H, Takahama S, Akita H, Kobayashi S, Masuta Y, Nagatsuka Y, Higashiguchi M, Tomokuni A, Yoshida K, Takahashi H, Doki Y, Eguchi H, Matsuura N, Yamamoto T. Murakami H, et al. Among authors: higashiguchi m. Front Immunol. 2024 Mar 14;15:1363568. doi: 10.3389/fimmu.2024.1363568. eCollection 2024. Front Immunol. 2024. PMID: 38550601 Free PMC article.
Regnase-1 downregulation promotes pancreatic cancer through myeloid-derived suppressor cell-mediated evasion of anticancer immunity.
Okabe J, Kodama T, Sato Y, Shigeno S, Matsumae T, Daiku K, Sato K, Yoshioka T, Shigekawa M, Higashiguchi M, Kobayashi S, Hikita H, Tatsumi T, Okamoto T, Satoh T, Eguchi H, Akira S, Takehara T. Okabe J, et al. Among authors: higashiguchi m. J Exp Clin Cancer Res. 2023 Oct 9;42(1):262. doi: 10.1186/s13046-023-02831-w. J Exp Clin Cancer Res. 2023. PMID: 37814340 Free PMC article.
58 results